Paper38319085
Small molecule inhibitors of transcriptional cyclin-dependent kinases impose HIV-1 latency, presenting "block and lock" treatment strategies.
Horvath RM and 2 others. Antimicrob Agents Chemother, 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Small molecule inhibitors of transcriptional cyclin-dependent kinases impose HIV-1 latency, presenting "block and lock" treatment strategies. Papers, record 38319085. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38319085
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Small molecule inhibitors of transcriptional cyclin-dependent kinases impose HIV-1 latency, presenting "block and lock" treatment strategies.
- PubMed
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HIV-1 | Major topic |
| Cyclin-Dependent Kinases | |
| Cyclin-Dependent Kinase 9 | |
| Cyclins |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| F16-01210 | Gouvernement du Canada | Canadian Institutes of Health Research (IRSC) | PubMed | ||
| F19-05392 | Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC) | PubMed | ||
| PJT-159625 | Gouvernement du Canada | Canadian Institutes of Health Research (IRSC) | PubMed | ||
| Michael Smith Health Research BC (MSFHR) | PubMed |
Source PubMed
References86
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27428432 | The Effect of Latency Reversal Agents on Primary CD8+ T Cells: Implications for Shock and Kill Strategies for Human Immunodeficiency Virus Eradication. | EBioMedicine | 2016 | https://conductscience.org/library/papers/27428432 | PubMed |
| 2 | 33577894 | Flavonoid-based inhibition of cyclin-dependent kinase 9 without concomitant inhibition of histone deacetylases durably reinforces HIV latency. | Biochem Pharmacol | 2021 | https://conductscience.org/library/papers/33577894 | PubMed |
| 3 | 27477907 | Engineered Covalent Inactivation of TFIIH-Kinase Reveals an Elongation Checkpoint and Results in Widespread mRNA Stabilization. | Mol Cell | 2016 | https://conductscience.org/library/papers/27477907 | PubMed |
| 4 | 33640324 | Regulation of Promoter Proximal Pausing of RNA Polymerase II in Metazoans. | J Mol Biol | 2021 | https://conductscience.org/library/papers/33640324 | PubMed |
| 5 | 21752913 | The HIV-1 Tat protein has a versatile role in activating viral transcription. | J Virol | 2011 | https://conductscience.org/library/papers/21752913 | PubMed |
| 6 | 18794900 | CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. | Nature | 2008 | https://conductscience.org/library/papers/18794900 | PubMed |
| 7 | 19136668 | Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells. | J Biol Chem | 2009 | https://conductscience.org/library/papers/19136668 | PubMed |
| 8 | 28689087 | The histone deacetylase inhibitor SAHA simultaneously reactivates HIV-1 from latency and up-regulates NKG2D ligands sensitizing for natural killer cell cytotoxicity. | Virology | 2017 | https://conductscience.org/library/papers/28689087 | PubMed |
| 9 | 31123063 | Promoter-proximal pausing of RNA polymerase II: a nexus of gene regulation. | Genes Dev | 2019 | https://conductscience.org/library/papers/31123063 | PubMed |
| 10 | 26984732 | HIV Provirus Stably Reproduces Parental Latent and Induced Transcription Phenotypes Regardless of the Chromosomal Integration Site. | J Virol | 2016 | https://conductscience.org/library/papers/26984732 | PubMed |
| 11 | 35781526 | Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/35781526 | PubMed |
| 12 | 26152583 | The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency. | mBio | 2015 | https://conductscience.org/library/papers/26152583 | PubMed |
| 13 | 37378433 | CDK8 and CDK19: positive regulators of signal-induced transcription and negative regulators of Mediator complex proteins. | Nucleic Acids Res | 2023 | https://conductscience.org/library/papers/37378433 | PubMed |
| 14 | 22012619 | The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes. | Genes Dev | 2011 | https://conductscience.org/library/papers/22012619 | PubMed |
| 15 | 37671866 | CDK8 inhibitors antagonize HIV-1 reactivation and promote provirus latency in T cells. | J Virol | 2023 | https://conductscience.org/library/papers/37671866 | PubMed |
| 16 | 32038533 | Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs. | Front Microbiol | 2019 | https://conductscience.org/library/papers/32038533 | PubMed |
| 17 | 12097601 | Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteins. | J Virol | 2002 | https://conductscience.org/library/papers/12097601 | PubMed |
| 18 | 35193797 | The Mediator kinase module: an interface between cell signaling and transcription. | Trends Biochem Sci | 2022 | https://conductscience.org/library/papers/35193797 | PubMed |
| 19 | 33334019 | Block-And-Lock: New Horizons for a Cure for HIV-1. | Viruses | 2020 | https://conductscience.org/library/papers/33334019 | PubMed |
| 20 | 11431468 | Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11431468 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42370638 | RNA polymerase II phosphorylation dynamics: from molecular mechanisms to human disease. | RNA Biol | 2026 | https://conductscience.org/library/papers/42370638 | PubMed |
| 42357682 | Histone Deacetylase Inhibitors (HDACis) as Latency-Reversing Agents in HIV Cure Strategies: Chemistry, Selectivity, and Clinical Perspective. | Viruses | 2026 | https://conductscience.org/library/papers/42357682 | PubMed |
| 42074139 | Block-and-Lock Approaches for HIV Cure: Mechanistic Insights, Challenges, and Emerging Role of CPSF6. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074139 | PubMed |
| 39931979 | Cyclin Dependent Kinases in Antiviral Drug Discovery. | Curr Med Chem | 2025 | https://conductscience.org/library/papers/39931979 | PubMed |
| 39865804 | CDK8 as a Therapeutic Target for Overall Survival Prediction in Cervical Squamous Cell Carcinoma (CESC). | Curr Cancer Drug Targets | 2026 | https://conductscience.org/library/papers/39865804 | PubMed |
| 39163135 | Mechanisms and efficacy of small molecule latency-promoting agents to inhibit HIV reactivation ex vivo. | JCI Insight | 2024 | https://conductscience.org/library/papers/39163135 | PubMed |
| 38674696 | Targeting Viral Transcription for HIV Cure Strategies. | Microorganisms | 2024 | https://conductscience.org/library/papers/38674696 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CDK19 | 23097 | PubTator's text mining | https://conductscience.org/library/genes/23097 | NCBI Gene |
| CDK7 | 1022 | PubTator's text mining | https://conductscience.org/library/genes/1022 | NCBI Gene |
| CDK8 | 1024 | PubTator's text mining | https://conductscience.org/library/genes/1024 | NCBI Gene |
| CDK9 | 1025 | PubTator's text mining | https://conductscience.org/library/genes/1025 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38319085
GET https://conductscience.org/api/papers/v1/38319085/references?page=2